Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.96 USD | +7.72% | +8.53% | +229.02% |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call | |
May. 13 | Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+229.02% | 364M | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Jasper Therapeutics : Shares Soar Midday After Initiated by Oppenheimer With Outperform Rating, $21 Price Target